Clinical Study
Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing
Table 4
Frequencies of selected HLA-DRB1 alleles in alopecia patients compared to controls using Chi square test.
| DRB1 allele | Controls (n = 580) | Overall alopecia (n = 54) | P value | LAA (n = 18) | P value | AT/AU (n = 36) | P value |
| HLA-DRB1*01 | 5% | 5.6% | .998 | 0% | .083 | 5.6% | .954 | HLA-DRB1*03 | 19% | 22.2% | .992 | 5.5% | .000* | 16.6% | .515 | HLA-DRB1*04 | 16% | 16.7% | 1.0 | 11.1% | .223 | 5.6% | .006** | HLA-DRB1*07 | 6% | 11.1% | .31 | 0% | .04* | 11.1% | .088 | HLA-DRB1*08 | 2% | 5.6% | .28 | 0% | .911 | 5.6% | .002** | HLA-DRB1*11 | 12% | 22.2% | .048* | 11.1% | .735 | 11.1% | .735 | HLA-DRB1*13 | 16% | 5.6% | .021* | 0% | .00** | 5.6% | .003** | HLA-DRB1*15 | 7% | 11.1% | .459 | 5.5% | .658 | 5.6% | .658 |
|
|
AT: alopecia totalis; AU: alopecia universalis; LAA: localized alopecia ateata
*statistically significant difference
**statistically highly significant difference
|